Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12615000476538
ACTRN12615000476538
Active, not recruiting
未知

Patients with solid tumours that are accessible can bank their tumours in a dedicated tumour bank for long term fresh frozen storage conditions for the possible future production of an autologous cancer vaccine, the latter being a separate study.

Regeneus Ltd0 sites60 target enrollmentMay 14, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSolid tumoursCancer - Any cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Solid tumours
Sponsor
Regeneus Ltd
Enrollment
60
Status
Active, not recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 14, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Adults 18 years of age and over
  • •\- Planned surgery as routine treatment for cancer from which tumour can be sourced
  • •\- In the investigator's opinion, has a tumour of a size that is likely to yield at least 1 cm3

Exclusion Criteria

  • •\- Treatment for cancer in the 4 weeks prior to tumour excision surgery
  • •\- Current or past history of active autoimmune disease
  • •\- Known HIV infection
  • •\- Chronic hepatitis
  • •\- History of organ transplant or other condition requiring immunosuppressant medications
  • •\- Chronic systemic corticosteroid therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Allocation of patients with relapse of cancer to treatment with new drugs based on tumor biopsy
EUCTR2019-002071-34-DKVejle Hospital40
Active, not recruiting
Not Applicable
Treatment of Patients Suffering from Tumour Cachexia with Dronabinol (tetrahydrocannabinol) or PlaceboComparison of individually optimised dosages in a double blind, randomised parallel design - Dronabinol for tumour cachexia
EUCTR2007-002968-10-ATDepartment of Medicine I, Clinical Dep. f. Oncology, University Hospital,74
Suspended
Not Applicable
Elucidation of pathologic condition in tumor using F-18 FLT PETPatients with or suspected tumor
JPRN-UMIN000043739Kagawa University50
Suspended
Not Applicable
Elucidation of pathologic condition in tumor using F-18 FMISO PETPatients with or suspected tumor
JPRN-UMIN000043738Kagawa University50
Suspended
Not Applicable
Elucidation of pathologic condition in tumor using C-11 methionine PETPatients with or suspected tumor
JPRN-UMIN000043741Faculty of Medicine, Kagawa University200